Previous research has reported that a PPARG Pro12Ala polymorphism was associated with dyslipidemia and cardiovascular disease [44] because PPAR-γ regulates the expression of key proteins involved in lipid metabolism. This evidence concerns the gene PPARG and cardiovascular disorder.